| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 349.61M | 240.78M | 199.34M | 326.49M | 511.57M | 446.85M |
| Gross Profit | 7.21M | 8.48M | 4.57M | 3.99M | 18.87M | 8.86M |
| EBITDA | 11.28M | 11.60M | 10.07M | 15.82M | 16.44M | 15.84M |
| Net Income | 1.15M | 1.05M | 2.42M | 810.00K | 2.96M | 652.00K |
Balance Sheet | ||||||
| Total Assets | 240.13M | 221.14M | 224.08M | 214.17M | 222.79M | 201.97M |
| Cash, Cash Equivalents and Short-Term Investments | 5.56M | 5.75M | 3.87M | 17.22M | 11.88M | 7.03M |
| Total Debt | 1.66M | 5.40M | 5.17M | 2.15M | 3.39M | 35.86M |
| Total Liabilities | 150.80M | 132.00M | 136.00M | 128.51M | 142.00M | 124.14M |
| Stockholders Equity | 89.33M | 89.14M | 88.08M | 85.66M | 80.79M | 77.83M |
Cash Flow | ||||||
| Free Cash Flow | 6.30M | 10.51M | -8.89M | 3.50M | 31.13M | 13.90M |
| Operating Cash Flow | 12.96M | 15.15M | -4.27M | 11.66M | 41.21M | 28.75M |
| Investing Cash Flow | -5.18M | -4.44M | -3.49M | -7.74M | -9.39M | -14.76M |
| Financing Cash Flow | -10.26M | -10.81M | -5.59M | 1.42M | -25.90M | -13.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$353.76M | 1.21 | 11.24% | ― | 20.41% | 188.08% | |
71 Outperform | HK$155.94M | 3.77 | 10.87% | 23.73% | -32.31% | -51.89% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$22.18B | 659.69 | 1.29% | ― | 78.48% | -33.33% | |
53 Neutral | HK$120.61M | 10.08 | 2.70% | ― | -27.58% | -18.28% | |
47 Neutral | HK$70.56M | -5.35 | -9.80% | ― | 3.97% | 14.02% | |
41 Neutral | HK$129.61M | -36.13 | -0.68% | 7.69% | -33.92% | -94.74% |